Central role of PI3K–SYK interaction in fibrinogen-induced lamellipodia and filopodia formation in platelets

FEBS Open Bio

Volumn 6, Issue 12, 2016, Pages 1285-1296

  Singh, Raghvendra ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY KANPUR   (India)

Author keywords

filopodia; lamellipodia; response time; Sos; WASP; WAVE

Indexed keywords

ACTIN RELATED PROTEIN 2-3 COMPLEX; FIBRINOGEN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; MULTIPROTEIN COMPLEX; NEURAL WISKOTT ALDRICH SYNDROME PROTEIN; NUCLEOSOME ASSEMBLY PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN CDC42; PROTEIN KINASE SYK; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SOS PROTEIN; UNCLASSIFIED DRUG; VAV PROTEIN; WASP COMPLEX; WAVE COMPLEX 1;

ACTIN POLYMERIZATION; ARTICLE; COMPLEX FORMATION; FILOPODIUM; LAMELLIPODIUM; MATHEMATICAL MODEL; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE AGGREGATION;

EID: 85002328339     PISSN: 22115463     EISSN: None     Source Type: Journal    
DOI: 10.1002/2211-5463.12149     Document Type: Article

References (61)

1. Savage B, Saldivar E and Ruggeri ZM (1996) Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 84, 289–297.
2. Offermanns S (2006) Activation of platelet function through G protein-coupled receptors. Circ Res 99, 1293–1304.
3. Small JV, Stradal T, Vignal E and Rottner K (2002) The lamellipodium: where motility begins. Trends Cell Biol 12, 112–120.
4. Tapon N and Hall A (1997) Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton. Curr Opin Cell Biol 9, 86–92.
5. Aoki K, Nakamura T, Fujikawa K and Matsuda M (2005) Local phosphatidylinositol 3,4,5-trisphosphate accumulation recruits Vav2 and Vav3 to activate Rac1/Cdc42 and initiate neurite outgrowth in nerve growth factor-stimulated PC12 cells. Mol Biol Cell 16, 2207–2217.
6. Han J, Luby-Phelps K, Das B, Shu X, Xia Y, Mosteller RD, Krishna UM, Falck JR, White MA and Broek D (1998) Role of substrates and products of PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav. Science 279, 558–560.
7. Innocenti M, Frittoli E, Ponzanelli I, Falck JR, Brachmann SM, Di Fiore PP and Scita G (2003) Phosphoinositide 3-kinase activates Rac by entering in a complex with Eps8, Abi1, and Sos-1. J Cell Biol 160, 17–23.
8. Scita G, Nordstrom J, Carbone R, Tenca P, Giardina G, Gutkind S, Bjarnegard M, Betsholtz C and Di Fiore PP (1999) EPS8 and E3B1 transduce signals from Ras to Rac. Nature 401, 290–293.
9. Zheng Y, Glaven JA, Wu WJ and Cerione RA (1996) Phosphatidylinositol 4,5-bisphosphate provides an alternative to guanine nucleotide exchange factors by stimulating the dissociation of GDP from Cdc42Hs. J Biol Chem 271, 23815–23819.
10. Jimenez C, Portela RA, Mellado M, Rodriguez-Frade JM, Collard J, Serrano A, Martinez AC, Avila J and Carrera AC (2000) Role of the PI3K regulatory subunit in the control of actin organization and cell migration. J Cell Biol 151, 249–262.
11. Mocsai A, Ruland J and Tybulewicz VL (2010) The SYK tyrosine kinase: a crucial player in diverse biological functions. Nat Rev Immunol 10, 387–402.
12. Woodside DG, Obergfell A, Leng L, Wilsbacher JL, Miranti CK, Brugge JS, Shattil SJ and Ginsberg MH (2001) Activation of Syk protein tyrosine kinase through interaction with integrin beta cytoplasmic domains. Curr Biol 11, 1799–1804.
13. Weinblatt ME, Kavanaugh A, Genovese MC, Musser TK, Grossbard EB and Magilavy DB (2010) An oral spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis. N Engl J Med 363, 1303–1312.
14. Geahlen RL (2014) Getting Syk: spleen tyrosine kinase as a therapeutic target. Trends Pharmacol Sci 35, 414–422.
15. Colonna L, Catalano G, Chew C, D'Agati V, Thomas JW, Wong FS, Schmitz J, Masuda ES, Reizis B, Tarakhovsky A et al. (2010) Therapeutic targeting of Syk in autoimmune diabetes. J Immunol 185, 1532–1543.
16. Pamuk ON, Lapchak PH, Rani P, Pine P, Dalle Lucca JJ and Tsokos GC (2010) Spleen tyrosine kinase inhibition prevents tissue damage after ischemia-reperfusion. Am J Physiol Gastrointest Liver Physiol 299, G391–G399.
17. Ghotra VP, He S, van der Horst G, Nijhoff S, de Bont H, Lekkerkerker A, Janssen R, Jenster G, van Leenders GJ, Hoogland AM et al. (2015) SYK is a candidate kinase target for the treatment of advanced prostate cancer. Cancer Res 75, 230–240.
18. Puissant A, Fenouille N, Alexe G, Pikman Y, Bassil CF, Mehta S, Du J, Kazi JU, Luciano F, Ronnstrand L et al. (2014) SYK is a critical regulator of FLT3 in acute myeloid leukemia. Cancer Cell 25, 226–242.
19. Yu Y, Gaillard S, Phillip JM, Huang TC, Pinto SM, Tessarollo NG, Zhang Z, Pandey A, Wirtz D, Ayhan A et al. (2015) Inhibition of spleen tyrosine kinase potentiates paclitaxel-induced cytotoxicity in ovarian cancer cells by stabilizing microtubules. Cancer Cell 28, 82–96.
20. Flynn R, Allen JL, Luznik L, MacDonald KP, Paz K, Alexander KA, Vulic A, Du J, Panoskaltsis-Mortari A, Taylor PA et al. (2015) Targeting Syk-activated B cells in murine and human chronic graft-versus-host disease. Blood 125, 4085–4094.
21. Krisenko MO and Geahlen RL (2015) Calling in SYK: SYK's dual role as a tumor promoter and tumor suppressor in cancer. Biochim Biophys Acta 1853, 254–263.
22. Coopman PJ, Do MT, Barth M, Bowden ET, Hayes AJ, Basyuk E, Blancato JK, Vezza PR, McLeskey SW, Mangeat PH et al. (2000) The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells. Nature 406, 742–747.
23. Obergfell A, Eto K, Mocsai A, Buensuceso C, Moores SL, Brugge JS, Lowell CA and Shattil SJ (2002) Coordinate interactions of Csk, Src, and Syk kinases with [alpha]IIb[beta]3 initiate integrin signaling to the cytoskeleton. J Cell Biol 157, 265–275.
24. Arias-Salgado EG, Haj F, Dubois C, Moran B, Kasirer-Friede A, Furie BC, Furie B, Neel BG and Shattil SJ (2005) PTP-1B is an essential positive regulator of platelet integrin signaling. J Cell Biol 170, 837–845.
25. Gao J, Zoller KE, Ginsberg MH, Brugge JS and Shattil SJ (1997) Regulation of the pp72syk protein tyrosine kinase by platelet integrin alpha IIb beta 3. EMBO J 16, 6414–6425.
26. Jiang K, Zhong B, Gilvary DL, Corliss BC, Vivier E, Hong-Geller E, Wei S and Djeu JY (2002) Syk regulation of phosphoinositide 3-kinase-dependent NK cell function. J Immunol 168, 3155–3164.
27. Taniguchi CM, Tran TT, Kondo T, Luo J, Ueki K, Cantley LC and Kahn CR (2006) Phosphoinositide 3-kinase regulatory subunit p85alpha suppresses insulin action via positive regulation of PTEN. Proc Natl Acad Sci USA 103, 12093–12097.
28. Chagpar RB, Links PH, Pastor MC, Furber LA, Hawrysh AD, Chamberlain MD and Anderson DH (2010) Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase. Proc Natl Acad Sci USA 107, 5471–5476.
29. Gericke A, Munson M and Ross AH (2006) Regulation of the PTEN phosphatase. Gene 374, 1–9.
30. Miranti CK, Leng L, Maschberger P, Brugge JS and Shattil SJ (1998) Identification of a novel integrin signaling pathway involving the kinase Syk and the guanine nucleotide exchange factor Vav1. Curr Biol 8, 1289–1299.
31. Bustelo XR (1996) The VAV family of signal transduction molecules. Crit Rev Oncog 7, 65–88.
32. Kawakami Y, Kitaura J, Yao L, McHenry RW, Kawakami Y, Newton AC, Kang S, Kato RM, Leitges M, Rawlings DJ et al. (2003) A Ras activation pathway dependent on Syk phosphorylation of protein kinase C. Proc Natl Acad Sci USA 100, 9470–9475.
33. Reynolds LF, de Bettignies C, Norton T, Beeser A, Chernoff J and Tybulewicz VL (2004) Vav1 transduces T cell receptor signals to the activation of the Ras/ERK pathway via LAT, Sos, and RasGRP1. J Biol Chem 279, 18239–18246.
34. Caloca MJ, Zugaza JL, Matallanas D, Crespo P and Bustelo XR (2003) Vav mediates Ras stimulation by direct activation of the GDP/GTP exchange factor Ras GRP1. EMBO J 22, 3326–3336.
35. Roose JP, Mollenauer M, Ho M, Kurosaki T and Weiss A (2007) Unusual interplay of two types of Ras activators, RasGRP and SOS, establishes sensitive and robust Ras activation in lymphocytes. Mol Cell Biol 27, 2732–2745.
36. Lommel S, Benesch S, Rottner K, Franz T, Wehland J and Kuhn R (2001) Actin pedestal formation by enteropathogenic Escherichia coli and intracellular motility of Shigella flexneri are abolished in N-WASP-defective cells. EMBO Rep 2, 850–857.
37. Takenawa T and Suetsugu S (2007) The WASP-WAVE protein network: connecting the membrane to the cytoskeleton. Nat Rev Mol Cell Biol 8, 37–48.
38. Gautreau A, Ho HY, Li J, Steen H, Gygi SP and Kirschner MW (2004) Purification and architecture of the ubiquitous Wave complex. Proc Natl Acad Sci USA 101, 4379–4383.
39. Chen Z, Borek D, Padrick SB, Gomez TS, Metlagel Z, Ismail AM, Umetani J, Billadeau DD, Otwinowski Z and Rosen MK (2010) Structure and control of the actin regulatory WAVE complex. Nature 468, 533–538.
40. Eden S, Rohatgi R, Podtelejnikov AV, Mann M and Kirschner MW (2002) Mechanism of regulation of WAVE1-induced actin nucleation by Rac1 and Nck. Nature 418, 790–793.
41. Innocenti M, Zucconi A, Disanza A, Frittoli E, Areces LB, Steffen A, Stradal TE, Di Fiore PP, Carlier MF and Scita G (2004) Abi1 is essential for the formation and activation of a WAVE2 signalling complex. Nat Cell Biol 6, 319–327.
42. Soderling SH, Binns KL, Wayman GA, Davee SM, Ong SH, Pawson T and Scott JD (2002) The WRP component of the WAVE-1 complex attenuates Rac-mediated signalling. Nat Cell Biol 4, 970–975.
43. Ho HY, Rohatgi R, Lebensohn AM, Le M, Li J, Gygi SP and Kirschner MW (2004) Toca-1 mediates Cdc42-dependent actin nucleation by activating the N-WASP-WIP complex. Cell 118, 203–216.
44. Blundell MP, Bouma G, Metelo J, Worth A, Calle Y, Cowell LA, Westerberg LS, Moulding DA, Mirando S, Kinnon C et al. (2009) Phosphorylation of WASp is a key regulator of activity and stability in vivo. Proc Natl Acad Sci USA 106, 15738–15743.
45. Oda A, Ochs HD, Lasky LA, Spencer S, Ozaki K, Fujihara M, Handa M, Ikebuchi K and Ikeda H (2001) CrkL is an adapter for Wiskott-Aldrich syndrome protein and Syk. Blood 97, 2633–2639.
46. Higgs HN and Pollard TD (2000) Activation by Cdc42 and PIP(2) of Wiskott-Aldrich syndrome protein (WASp) stimulates actin nucleation by Arp2/3 complex. J Cell Biol 150, 1311–1320.
47. Rohatgi R, Ho HY and Kirschner MW (2000) Mechanism of N-WASP activation by CDC42 and phosphatidylinositol 4, 5-bisphosphate. J Cell Biol 150, 1299–1310.
48. Rohatgi R, Ma L, Miki H, Lopez M, Kirchhausen T, Takenawa T and Kirschner MW (1999) The interaction between N-WASP and the Arp2/3 complex links Cdc42-dependent signals to actin assembly. Cell 97, 221–231.
49. Singh R (2016) Model predicts that MKP1 and TAB 1 regulate p38alpha nuclear pulse and its basal activity through positive and negative feedback loops in response to IL-1. PLoS One 11, e0157572.
50. Tohyama Y, Tohyama K, Tsubokawa M, Asahi M, Yoshida Y and Yamamura H (1998) Outside-In signaling of soluble and solid-phase fibrinogen through integrin alphaIIbbeta3 is different and cooperative with each other in a megakaryoblastic leukemia cell line, CMK. Blood 92, 1277–1286.
51. Wood KW, Sarnecki C, Roberts TM and Blenis J (1992) ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSK. Cell 68, 1041–1050.
52. Paumelle R, Tulasne D, Kherrouche Z, Plaza S, Leroy C, Reveneau S, Vandenbunder B and Fafeur V (2002) Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway. Oncogene 21, 2309–2319.
53. Coso OA, Chiariello M, Yu JC, Teramoto H, Crespo P, Xu N, Miki T and Gutkind JS (1995) The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell 81, 1137–1146.
54. Nimnual AS, Yatsula BA and Bar-Sagi D (1998) Coupling of Ras and Rac guanosine triphosphatases through the Ras exchanger Sos. Science 279, 560–563.
55. Vo U, Vajpai N, Flavell L, Bobby R, Breeze AL, Embrey KJ and Golovanov AP (2016) Monitoring Ras interactions with the nucleotide exchange factor son of sevenless (Sos) using site-specific NMR reporter signals and intrinsic fluorescence. J Biol Chem 291, 1703–1718.
56. Innocenti M, Tenca P, Frittoli E, Faretta M, Tocchetti A, Di Fiore PP and Scita G (2002) Mechanisms through which Sos-1 coordinates the activation of Ras and Rac. J Cell Biol 156, 125–136.
57. Amann KJ and Pollard TD (2000) Cellular regulation of actin network assembly. Curr Biol 10, R728–R730.
58. Mejillano MR, Kojima S, Applewhite DA, Gertler FB, Svitkina TM and Borisy GG (2004) Lamellipodial versus filopodial mode of the actin nanomachinery: pivotal role of the filament barbed end. Cell 118, 363–373.
59. Beemiller P, Zhang Y, Mohan S, Levinsohn E, Gaeta I, Hoppe AD and Swanson JA (2010) A Cdc42 activation cycle coordinated by PI 3-kinase during Fc receptor-mediated phagocytosis. Mol Biol Cell 21, 470–480.
60. Kato T, Kawai K, Egami Y, Kakehi Y and Araki N (2014) Rac1-dependent lamellipodial motility in prostate cancer PC-3 cells revealed by optogenetic control of Rac1 activity. PLoS One 9, e97749.
61. van Weering DH and Bos JL (1997) Glial cell line-derived neurotrophic factor induces Ret-mediated lamellipodia formation. J Biol Chem 272, 249–254.